Thyroglobulin autoantibodies as surrogate biomarkers in the management of patients with differentiated thyroid carcinoma

MLA

Feldt-Rasmussen, U., et al. “Thyroglobulin Autoantibodies as Surrogate Biomarkers in the Management of Patients with Differentiated Thyroid Carcinoma.” Current Medicinal Chemistry, 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1284006003&authtype=sso&custid=ns315887.

APA

Feldt-Rasmussen, U., Verburg, F. A., Luster, M., Cupini, C., Chiovato, L., Duntas, L., Elisei, R., Rimmele, H., Seregni, E., Smit, J. W. A., Theimer, C., & Giovanella, L. (2014). Thyroglobulin autoantibodies as surrogate biomarkers in the management of patients with differentiated thyroid carcinoma. Current Medicinal Chemistry.

Chicago

Feldt-Rasmussen, U., F.A. Verburg, M. Luster, C. Cupini, L. Chiovato, L. Duntas, R. Elisei, et al. 2014. “Thyroglobulin Autoantibodies as Surrogate Biomarkers in the Management of Patients with Differentiated Thyroid Carcinoma.” Current Medicinal Chemistry. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1284006003&authtype=sso&custid=ns315887.